NASDAQ:CRVS | Free Cash Flow | Corvus Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2014-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$10.37M$91,000.00-$10.47M
2025-12-31-$9.19M$25,000.00-$9.22M
2025-03-31-$8.26M$36,000.00-$8.3M-54.62%
2024-12-31-$8.47M
2024-03-31-$5.16M
2023-12-31-$5.17M$0.00-$5.17M
2023-03-31-$8.11M$34,000.00-$8.15M
2022-12-31-$7.55M$0.00-$7.55M
2022-03-31-$6.42M
2021-12-31-$6.86M
2021-03-31-$8.79M
2020-12-31-$8.21M$0.00-$8.21M-30.01%
2020-03-31-$9.35M
2019-12-31-$8.51M$5,000.00-$8.52M
2019-03-31-$8.99M$16,000.00-$9.01M
2018-12-31-$8.26M$135,000.00-$8.39M
2018-03-31-$11.05M$6,000.00-$11.05M
2017-12-31-$10.98M-$8,000.00-$10.99M
2017-03-31-$12.75M$111,000.00-$12.86M
2016-12-31-$9.41M$613,000.00-$10.02M
2016-03-31-$5.64M$614,000.00-$6.25M
2015-12-31-$3.94M$864,000.00-$4.8M
2015-03-31-$2.32M$324,000.00-$2.65M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$32.8M$174,000.00-$32.97M
2024-12-31-$25.42M
2023-12-31-$23.94M$34,000.00-$23.97M
2022-12-31-$27.02M$269,000.00-$27.29M
2021-12-31-$36.72M$5,000.00-$36.72M
2020-12-31-$34.78M$76,000.00-$34.85M
2019-12-31-$37.32M$25,000.00-$37.35M
2018-12-31-$40.99M$355,000.00-$41.34M
2017-12-31-$46.21M$266,000.00-$46.48M
2016-12-31-$27.86M$2.2M-$30.06M
2015-12-31-$11.33M$1.75M-$13.08M
2014-12-31-$96,000.00